| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.280 | 26.250 | 29.880 | 32.614 | 40.246 | 39.516 | 39.119 | 43.536 | 62.100 | 67.292 |
| Total Income - EUR | 25.750 | 26.385 | 29.883 | 32.621 | 40.249 | 39.520 | 40.139 | 43.547 | 62.119 | 67.305 |
| Total Expenses - EUR | 8.456 | 8.469 | 9.142 | 13.168 | 12.613 | 7.617 | 7.622 | 8.863 | 13.281 | 12.173 |
| Gross Profit/Loss - EUR | 17.294 | 17.917 | 20.741 | 19.454 | 27.636 | 31.904 | 32.517 | 34.684 | 48.838 | 55.132 |
| Net Profit/Loss - EUR | 16.521 | 17.381 | 20.417 | 19.127 | 27.234 | 31.114 | 32.125 | 34.036 | 48.217 | 54.459 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Griflomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.310 | 1.245 | 1.135 | 1.002 | 888 | 685 | 319 | 44 | 44 | 44 |
| Current Assets | 21.604 | 22.245 | 30.499 | 30.791 | 26.809 | 30.879 | 36.424 | 44.947 | 49.176 | 55.415 |
| Inventories | 79 | 234 | 393 | 663 | 977 | 958 | 1.044 | 1.048 | 649 | 645 |
| Receivables | 2.222 | 2.488 | 4.666 | 4.726 | 5.918 | 5.764 | 5.668 | 5.667 | 11.613 | 268 |
| Cash | 19.304 | 19.524 | 25.440 | 25.401 | 19.914 | 24.156 | 29.712 | 38.232 | 36.914 | 54.502 |
| Shareholders Funds | 16.575 | 17.434 | 20.470 | 19.179 | 27.284 | 31.164 | 32.174 | 34.084 | 48.265 | 54.507 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.339 | 6.056 | 11.164 | 12.614 | 412 | 400 | 4.569 | 10.906 | 954 | 951 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Griflomed S.r.l.